Sort   by:  
 Page size 
UnknownHumoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose.
Not available
S-EPMC10799790 | biostudies-literature
UnknownNeutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination.
Not available
S-EPMC9024419 | biostudies-literature
UnknownSeverity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients.
Not available
S-EPMC8020981 | biostudies-literature
UnknownThe interferon landscape along the respiratory tract impacts the severity of COVID-19.
Not available
S-EPMC8373821 | biostudies-literature
UnknownD-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study.
Not available
S-EPMC7165144 | biostudies-literature
UnknownCenter-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation.
Not available
S-EPMC4670074 | biostudies-literature
Sort   by:  
 Page size